EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation

Seiichiro Katagiri, Mitsuru Moriyama, Seiichiro Yoshizawa, SungGi Chi, Yosuke Minami, Daigo Akahane

Annals of Hematology · 06.11.2026

DOI: 10.1007/s00277-026-07347-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 06.11.2026. Verfasst von Seiichiro Katagiri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Katagiri, S., Moriyama, M., Yoshizawa, S., Chi, S., Minami, Y., & Akahane, D. (2026). Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-026-07347-9

Vancouver

Katagiri S, Moriyama M, Yoshizawa S, Chi S, Minami Y, Akahane D. Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation. Annals of Hematology. 2026. doi:10.1007/s00277-026-07347-9

BibTeX
@article{Katagiri2026,
  author = {Katagiri, Seiichiro and Moriyama, Mitsuru and Yoshizawa, Seiichiro and Chi, SungGi and Minami, Yosuke and Akahane, Daigo},
  title = {Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07347-9}
}
Kostenlos starten →